Read more
12:45 PM ยท 3 June 2025

Hims & Hers shares gain on planned expansion into Europe ๐Ÿ“ˆ

Hims & Hers Health
Stocks
HIMS.US, Hims & Hers Health Inc
-
-

Hims & Hers (HIMS.US) is up more than 6% in pre-market trading today following news of its planned acquisition of the European platform, ZAVA. The acquisition is part of the company's strategy to expand its global operations.

The exact terms of the transaction are not yet known, but according to press reports, the deal will be an all-cash transaction and is expected to close in 2026. For the company, this presents an opportunity to expand operations in the UK, Germany, France, and Ireland.

The company has seen an impressive over 130% increase since the end of April, when the cooperation between Hims & Hers and Novo Nordisk for the distribution of Wegovy was announced. Hims' strongest revenue growth driver has been the sale of cheaper copycats of the weight-loss drugs, thanks to Novo Nordisk and Eli Lilly products being listed on drug shortage lists. When these drugs were removed from the list, the sale of copycats ceased to be legal, and the company's stock plummeted by over 62% from its February highs at its worst point. Currently, the company's stock has returned to around its February levels.

The company's stock is up over 6% in pre-market trading. Source: xStation

12 December 2025, 5:42 PM

Rivian Automotive: Rising star or a meteorite?

12 December 2025, 2:40 PM

US OPEN: Valuations under pressure amid deregulation spree

12 December 2025, 10:53 AM

DE40: DAX gains 0.5%๐Ÿ“ˆLufthansa surges almost 5% amid Kepler recommendation

12 December 2025, 7:59 AM

Broadcom shares drop 5% despite robust earnings and AI demand ๐Ÿ—ฝ

Join over 2 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissรฃo de Valores Mobiliรกrios (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits